Nicholas Investment Partners LP Makes New $6.21 Million Investment in HealthEquity, Inc. (NASDAQ:HQY)

Nicholas Investment Partners LP purchased a new position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 64,747 shares of the company's stock, valued at approximately $6,212,000. Nicholas Investment Partners LP owned 0.07% of HealthEquity as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Barclays PLC grew its stake in shares of HealthEquity by 209.3% during the third quarter. Barclays PLC now owns 166,492 shares of the company's stock valued at $13,628,000 after buying an additional 112,667 shares during the last quarter. Assenagon Asset Management S.A. purchased a new stake in HealthEquity in the fourth quarter worth about $1,452,000. Covea Finance bought a new position in shares of HealthEquity during the fourth quarter valued at approximately $1,727,000. Radnor Capital Management LLC increased its stake in shares of HealthEquity by 8.3% during the fourth quarter. Radnor Capital Management LLC now owns 5,690 shares of the company's stock valued at $546,000 after purchasing an additional 436 shares in the last quarter. Finally, Hennion & Walsh Asset Management Inc. bought a new stake in shares of HealthEquity during the fourth quarter valued at approximately $215,000. Institutional investors own 99.55% of the company's stock.

HealthEquity Stock Down 0.5%

NASDAQ:HQY traded down $0.47 during midday trading on Monday, reaching $97.76. 91,823 shares of the stock traded hands, compared to its average volume of 793,429. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The business has a 50-day moving average of $87.88 and a two-hundred day moving average of $97.12. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a market capitalization of $8.46 billion, a PE ratio of 89.33, a price-to-earnings-growth ratio of 1.60 and a beta of 0.45.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and reduced their price target for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. Barrington Research reiterated an "outperform" rating and set a $112.00 price target on shares of HealthEquity in a research note on Friday, April 11th. Wells Fargo & Company lifted their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. KeyCorp cut their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Finally, The Goldman Sachs Group decreased their price target on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research note on Thursday, March 27th. One analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, HealthEquity presently has an average rating of "Buy" and an average target price of $111.75.

Insider Buying and Selling at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the sale, the director now owns 84,969 shares in the company, valued at approximately $6,597,842.85. This trade represents a 6.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares in the company, valued at approximately $4,433,820.30. This represents a 13.55% decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.